Protalix BioTherapeutics, Inc. (AMEX:PLX) Q4 2024 Earnings Call Transcript March 17, 2025
Protalix BioTherapeutics, Inc. beats earnings expectations. Reported EPS is $0.09, expectations were $0.07.
Operator: Good morning, ladies and gentlemen, and welcome to the Protalix BioTherapeutics Fiscal Year 2024 Financial and Business Results Conference Call. As a reminder, this conference call is being recorded. I will now turn the conference over to your host, Mr. Mike Moyer of LifeSci Advisors,...
